Supreme Court Asked To Take Up Lupron Labeling Suit

Law360, Chicago (November 1, 2013, 5:50 PM EDT) -- A Nevada woman on Thursday petitioned the U.S. Supreme Court for a new trial in her suit accusing TAP Pharmaceutical Products Inc. and Abbott Laboratories of failing to warn her about the risks of their drug Lupron, claiming a federal judge was biased against her and excluded important evidence.

Karin Klein claims the Ninth Circuit erred when it upheld a lower court’s decision to keep from a jury old labels for Lupron showing the companies had previously warned of bone density loss and thyroid problems in...
To view the full article, register now.